ASIA: +91 96043 17127 | USA: 1 (347) 690-0211 | Translate : 

Covid-19

Florbetapir Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

report img

Florbetapir Market By Type (30 mL Vial and 50 mL Vial) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the florbetapir industry. The report analyzes and declares the historical and current trends analysis of the florbetapir industry and subsequently recommends the projected trends anticipated to be observed in the florbetapir market during the upcoming years.

The florbetapir market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire florbetapir market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the florbetapir industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the florbetapir industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the florbetapir market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the florbetapir industry.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the florbetapir sector. Key strategic developments in the florbetapir market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the florbetapir market are appropriately highlighted in the report.

Research and development activities by major pharmaceutical giants are driving the growth of the market. Prominent market players of PET scanning molecule such as Eli Lilly, Navidea Biopharmaceuticals, Piramal Healthcare, and GE healthcare focusing on developing new molecule for the early diagnosis of disorders such as Alzheimer's disease and other dementias. For instance, Eli Lilly revealed in its recent annual report that flortaucipir, a new molecule used as a PET tracer is in phase three of its clinical trial. Furthermore, pharmaceutical giants such as piramal and GE healthcare also concentrating on developing new molecule on positron emission tomography tracer for early diagnosis of cognitive impairment diseases.

Another factor responsible for the increasing demand for new PET tracers is unavailability efficient technique to diagnose dementia coupled with the rising geriatric population. As per numerous research studies Alzheimer's disease is directly related to aging, as a majority of the Alzheimer's disease cases are more from the age of 65.

The florbetapir market research report delivers an acute valuation and taxonomy of the florbetapir industry by practically splitting the market on the basis of different types, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the florbetapir industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the florbetapir industry is provided for the leading economies of the world.

The florbetapir market is segmented based on type and region. On the basis of type segmentation, the market is classified into 30 mL vial and 50 mL vial. In terms of region segmentation, the market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

logoThe taxonomy of the florbetapir industry by its scope and segmentation is as follows:

logoGlobal Florbetapir Market: By Type Segmentation Analysis (Customizable)

  • 30 mL Vial
  • 50 mL Vial

logoGlobal Florbetapir Market: Regional Segmentation Analysis (Customizable)

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Florbetapir market – Prodcut Type Analysis
    1. 2.1. Global Florbetapir Market – Prodcut Type Overview
    2. 2.2. Global Florbetapir Market Share, by Prodcut Type, 2019 & 2026 (USD Million)
    3. 2.3. 30 mL Vial
      1. 2.3.1. Global 30 mL Vial Florbetapir Market, 2016-2026 (USD Million)
    4. 2.4. 50 mL Vial
      1. 2.4.1. Global 50 mL Vial Florbetapir Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Florbetapir market – Regional Analysis
    1. 3.1. Global Florbetapir Market Regional Overview
    2. 3.2. Global Florbetapir Market Share, by Region, 2019 & 2026 (Value)
    3. 3.3. North America
      1. 3.3.1. North America Florbetapir Market size and forecast, 2016-2026
      2. 3.3.2. North America Florbetapir Market, by Country, 2019 & 2026 (USD Million)
      3. 3.3.3. North America Florbetapir Market, by Prodcut Type, 2016-2026
      4. 3.3.4. U.S.
      5. 3.3.5. Canada
    4. 3.4. Europe
      1. 3.4.1. Europe Florbetapir Market size and forecast, 2016-2026
      2. 3.4.2. Europe Florbetapir Market, by Country, 2019 & 2026 (USD Million)
      3. 3.4.3. Europe Florbetapir Market, by Prodcut Type, 2016-2026
      4. 3.4.4. Germany
      5. 3.4.5. France
      6. 3.4.6. U.K.
      7. 3.4.7. Italy
      8. 3.4.8. Spain
      9. 3.4.9. Rest of Europe
    5. 3.5. Asia Pacific
      1. 3.5.1. Asia Pacific Florbetapir Market size and forecast, 2016-2026
      2. 3.5.2. Asia Pacific Florbetapir Market, by Country, 2019 & 2026 (USD Million)
      3. 3.5.3. Asia Pacific Florbetapir Market, by Prodcut Type, 2016-2026
      4. 3.5.4. China
      5. 3.5.5. Japan
      6. 3.5.6. India
      7. 3.5.7. South Korea
      8. 3.5.8. South-East Asia
      9. 3.5.9. Rest of Asia Pacific
    6. 3.6. Latin America
      1. 3.6.1. Latin America Florbetapir Market size and forecast, 2016-2026
      2. 3.6.2. Latin America Florbetapir Market, by Country, 2019 & 2026 (USD Million)
      3. 3.6.3. Latin America Florbetapir Market, by Prodcut Type, 2016-2026
      4. 3.6.4. Brazil
      5. 3.6.5. Mexico
      6. 3.6.6. Rest of Latin America
    7. 3.7. The Middle-East and Africa
      1. 3.7.1. The Middle-East and Africa Florbetapir Market size and forecast, 2016-2026
      2. 3.7.2. The Middle-East and Africa Florbetapir Market, by Country, 2019 & 2026 (USD Million)
      3. 3.7.3. The Middle-East and Africa Florbetapir Market, by Prodcut Type, 2016-2026
      4. 3.7.4. GCC Countries
      5. 3.7.5. South Africa
      6. 3.7.6. Rest of Middle-East Africa
  4. CHAPTER 4. Company Profiles
    1. 4.1. Elli Lilly
      1. 4.1.1. Company Overview
      2. 4.1.2. Elli Lilly Revenue and Gross Margin
      3. 4.1.3. Product portfolio
      4. 4.1.4. Recent initiatives
  5. CHAPTER 5. Florbetapir — Industry Analysis
    1. 5.1. Florbetapir Market – Key Trends
      1. 5.1.1. Market Drivers
      2. 5.1.2. Market Restraints
      3. 5.1.3. Market Opportunities
    2. 5.2. Value Chain Analysis
    3. 5.3. Technology Roadmap and Timeline
    4. 5.4. Florbetapir Market – Attractiveness Analysis
      1. 5.4.1. By Prodcut Type
      2. 5.4.2. By Region
  6. CHAPTER 6. Marketing Strategy Analysis, Distributors
    1. 6.1. Marketing Channel
    2. 6.2. Direct Marketing
    3. 6.3. Indirect Marketing
    4. 6.4. Marketing Channel Development Trend
    5. 6.5. Economic/Political Environmental Change
  7. CHAPTER 7. Report Conclusion
  8. CHAPTER 8. Research Approach & Methodology
    1. 8.1. Report Description
    2. 8.2. Research Scope
    3. 8.3. Research Methodology
      1. 8.3.1. Secondary Research
      2. 8.3.2. Primary Research
      3. 8.3.3. Models

      List of Figures

      FIG. 1 Global Florbetapir Market, 2016-2026 (USD Million)
      FIG. 2 Global Florbetapir Market Share, by Prodcut Type, 2019 & 2026 (USD Million)
      FIG. 3 Global 30 mL Vial Florbetapir Market, 2016-2026 (USD Million)
      FIG. 4 Global 50 mL Vial Florbetapir Market, 2016-2026 (USD Million)
      FIG. 5 Global Florbetapir Market Share, by Region, 2019 & 2026
      FIG. 6 North America Florbetapir Market, 2016-2026
      FIG. 7 U.S. Florbetapir Market, 2016-2026
      FIG. 8 Canada Florbetapir Market, 2016-2026
      FIG. 9 Europe Florbetapir Market, 2016-2026
      FIG. 10 Germany Florbetapir Market, 2016-2026
      FIG. 11 France Florbetapir Market, 2016-2026
      FIG. 12 U.K. Florbetapir Market, 2016-2026
      FIG. 13 Italy Florbetapir Market, 2016-2026
      FIG. 14 Spain Florbetapir Market, 2016-2026
      FIG. 15 Rest of Europe Florbetapir Market, 2016-2026
      FIG. 16 Asia Pacific Florbetapir Market, 2016-2026
      FIG. 17 China Florbetapir Market, 2016-2026
      FIG. 18 Japan Florbetapir Market, 2016-2026
      FIG. 19 India Florbetapir Market, 2016-2026
      FIG. 20 South  Korea Florbetapir Market, 2016-2026
      FIG. 21 South-East Asia Florbetapir Market, 2016-2026
      FIG. 22 Rest of Asia Pacific Florbetapir Market, 2016-2026
      FIG. 23 Latin America Florbetapir Market, 2016-2026
      FIG. 24 Brazil Florbetapir Market, 2016-2026
      FIG. 25 Mexico Florbetapir Market, 2016-2026
      FIG. 26 Rest of Latin America Florbetapir Market, 2016-2026
      FIG. 27 The Middle-East and Africa Florbetapir Market, 2016-2026
      FIG. 28 GCC Countries Florbetapir Market, 2016-2026
      FIG. 29 South Africa Florbetapir Market, 2016-2026
      FIG. 30 Rest of Middle-East Africa Florbetapir Market, 2016-2026
      FIG. 31 Elli Lilly Revenue and Growth Rate
      FIG. 32 Elli Lilly Market Share
      FIG. 33 Market Dynamics
      FIG. 34 Global Florbetapir – Value Chain Analysis
      FIG. 35 Technology Roadmap and Timeline
      FIG. 36 Market Attractiveness Analysis – By Prodcut Type
      FIG. 37 Market Attractiveness Analysis – By Region
      FIG. 38 Market Channel
      FIG. 39 Marketing Channel Development Trend
      FIG. 40 Growth in World Gross Product, 2008-2018

      List of Tables

      TABLE 1 Global Florbetapir Market, 2019 & 2026 (USD Million)
      TABLE 2 Global Florbetapir market, by Prodcut Type, 2016-2026 (USD Million)
      TABLE 3 Global Florbetapir market, by Region, 2016-2026 (USD Million)
      TABLE 4 North America Florbetapir Market, by Prodcut Type, 2016-2026 (USD Million)
      TABLE 5 Europe Florbetapir Market, by Prodcut Type, 2016-2026 (USD Million)
      TABLE 6 Asia Pacific Florbetapir Market, by Prodcut Type, 2016-2026 (USD Million)
      TABLE 7 Latin America Florbetapir Market, by Prodcut Type, 2016-2026 (USD Million)
      TABLE 8 The Middle-East and Africa Florbetapir Market, by Prodcut Type, 2016-2026 (USD Million)
      TABLE 9 Market Drivers
      TABLE 10 Market Restraints
      TABLE 11 Market Opportunities
      

Key Insights from Primary Research

  • According to the interview with industry participants, the florbetapir market is anticipated to expand at a significant rate over the forecast period i.e. a compound annual growth rate of around 3.6% by 2026 end over 2019 market value
  • The North America region was accounted for around half of the market share of total revenue generated in 2019
  • FDA approved Amyvid for the application in patients evaluated with cognitive decline especially Alzheimer's disease in April 2012
  • Rising prevalence of dementia is the chief reason behind the development of the florbetapir molecule
  • Growing geriatric population is also another factor responsible for the growth of the market, especially in the U.S. and Western Europe

Key Recommendations from Analysts

  • As per our analyst, Elli Lilly has the monopoly in the florbetapir market as the product has been patented by the company
  • Among the product type segment, the 30mL vial segment accounts for more than half of the value share in 2019
  • Robust research and development activities and investment in the clinical trials are anticipated to fuel the product demand over the forecast period
  • Another factor responsible for the increasing demand for new PET tracers is unavailability efficient technique to diagnose dementia
  • Prominent market players of PET scanning molecule such as Eli Lilly, Navidea Biopharmaceuticals, Piramal Healthcare, and GE healthcare focusing on developing new molecule for the early diagnosis of disorders such as Alzheimer's disease and other dementias

Florbetapir (Amyvid) Market Value Share (%) by Region, 2019

Florbetapir Market

Industry Major Market Players

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Florbetapir Market.
According to Facts and Factors research report, the global Florbetapir Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Florbetapir Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Florbetapir Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Florbetapir Market in North America over coming decade.
key questions and why choose us

Related Reports

report img

Corporate Wellness Market

[205+ Pages Report] According to a Facts and Factors market research report, the globalcorporate wellness solutions market is projected to reach USD 100 Billion by 2026 from USD 61.3 Billion in 2020, at a CAGR of 8.5% during the forecast period. Global Corporate Wellness Market: Overview Corpo...

Published Date : 27-Sep-2021 | | Category : | Pages : 205 | Format : Read more

Inquiry for Buying Request Sample
report img

Medical Polymers Market

[203+ Pages Report] According to a survey released by Facts and Factors, the globalmedical polymers market was valued at USD 16,500 Million in 2020 and is predicted to reach USD 28,290 Million by the end of 2026, rising at a CAGR of nearly 9.40% between 2021 and 2026. Global Medical Polymers Mar...

Published Date : 08-Sep-2021 | | Category : | Pages : 203 | Format : Read more

Inquiry for Buying Request Sample